EpiEndo and AlveoliX achieve milestone in ulcerative colitis treatment
Collaboration yields promising Barriolide therapy Enterothelin
Read More
Tag: EpiEndo
EpiEndo successfully completes phase 1 study into respiratory treatment
Orally available EP395 has met all endpoints in safety and is now undergoing phase 2 planning
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
